Annex

United Kingdom

The entry corresponding to triclabendazole in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active substance Marker residue Animal species MRL Target tissues Other provisions(according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Triclabendazole Sum of the extractable residues that may be oxidised to ketotriclabendazole All ruminants 225 μg/kg Muscle Antiparasitic agents/agents against endoparasites’
100 μg/kg Fat
250 μg/kg Liver
150 μg/kg Kidney
10 μg/kg Milk Provisional MRL shall expire on 1 January 2014

Pharmacologically active substance	Marker residue	Animal species	MRL	Target tissues	Other provisions(according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Triclabendazole	Sum of the extractable residues that may be oxidised to ketotriclabendazole	All ruminants	225 μg/kg	Muscle		Antiparasitic agents/agents against endoparasites’
			100 μg/kg	Fat
			250 μg/kg	Liver
			150 μg/kg	Kidney
			10 μg/kg	Milk	Provisional MRL shall expire on 1 January 2014